Aderhold Neuroleptika minimieren 6.0 - BGSP

32102 Suvisaari J, Perälä J, Saarni SI, Härkänen T, Pirkola S, Joukamaa M, Koskinen S, Lönnqvist J, Reunanen A.(2008):Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur ArchPsychiatry Clin Neurosci. 2008 Apr;258(3):129-36.103 Ryan MC, Collins P, Thakore JH.(2003): Impaired fasting glucose tolerance in first-episode, drug-naive patients withschizophrenia. Am J Psychiatry. 160(2):284-9.Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH.(2007) Impaired glucose tolerance in first-episode drug-naïvepatients with schizophrenia. Diabet Med. 24(5):481-5.104 Arranz B, Rosel P, Ramírez N, Dueñas R, Fernández P, Sanchez JM, Navarro MA, San L.(2004): Insulin resistance andincreased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episodeschizophrenia patients. J Clin Psychiatry. 65(10):1335-42.105 Witchel HJ, Hancox JC, Nutt DJ.(2003): Psychotropic drugs, cardiac arrhythmia, and sudden death. J ClinPsychopharmacol. 23(1):58-77.106 Newcomer JW.(2005): Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literaturereview. CNS Drugs. 19 Suppl 1:1-93.107 Robinson DS (2006) Insulin Secretion and Psychotropic Drugs. Primary Psychiatry. 13(12):26-27Gautam D, Han SJ, Hamdan FF, et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulinrelease and blood glucose homeostasis in vivo. Cell Metab. 2006;3(6):449-461.Johnson DE, Yamazaki H, Ward MK, et al. Inhibitory effects of antipsychotics on carbachol-induced insulin secretion fromperfused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia. Diabetes.2005;54(5):1552-1558.Renuka TR, Robinson R, Paulose CS. Increased insulin secretion by muscarinic M1 and M3 receptor function from ratpancreatic islets in vitro. Neurochem Res. 2006;31(3):313-320.108 Scheen AJ, De Hert MA. (2007): Abnormal glucose metabolism in patients treated with antipsychotics. DiabetesMetab. 33(3):169-75.109 Robinson DS (2006) Insulin Secretion and Psychotropic Drugs. Primary Psychiatry. 13(12):26-27110Haddad PM, Anderson IM (2002): Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs.62:1649-1671.Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. (2000): QTc-interval abnormalities and psychotropic drug therapy inpsychiatric patients. Lancet. 355:1048- 1052.Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. (2001): Antipsychotics and the risk of sudden cardiacdeath. Arch Gen Psychiatry. 58:1161-1167.Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH.(2002): Thioridazine and sudden unexplained death in psychiatric inpatients.Br J Psychiatry. 180:515- 522.Hennessy S, Bilker WB, Knauss JS, et al. (2002): Cardiac arrest and ventricular arrhythmia in patients taking antipsychoticdrugs: cohort study using administrative data. BMJ. 325:1070.Bralet MC, Yon V, Loas G, Noisette C.(2000):[Cause of mortality in schizophrenic patients: prospective study of years of acohort of 150 chronic schizophrenic patients][Article in French] Encephale. 26(6):32-41111 Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB.(2007): Relative risk of cardiovascular and cancermortality in people with severe mental illness from the United Kingdom's General Practice Research Database.Arch Gen Psychiatry. 64(2):242-9.112 Enger C, Weatherby L, Reynolds RF, Glasser DB, Walker AM.(2004): Serious cardiovascular events and mortality amongpatients with schizophrenia. J Nerv Ment Dis. 192(1):19-27